Sagimet Biosciences Inc Series A (SGMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||
| Net Income | -45,567 | -27,876 | -30,499 |
| Depreciation Amortization | -1,253 | -37 | -212 |
| Other Working Capital | -1,048 | -978 | 4,214 |
| Other Operating Activity | 5,433 | 5,125 | 2,007 |
| Operating Cash Flow | $-42,435 | $-23,766 | $-24,490 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -61,683 | 12,580 | -32,010 |
| Investing Cash Flow | $-61,683 | $12,580 | $-32,010 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 105,864 | 89,685 | 12 |
| Other Financing Activity | -1,045 | -3,518 | -85 |
| Financing Cash Flow | $104,819 | $86,167 | $-73 |
| Beginning Cash Position | 75,139 | 158 | 56,731 |
| End Cash Position | 75,840 | 75,139 | 158 |
| Net Cash Flow | $701 | $74,981 | $-56,573 |
| Free Cash Flow | |||
| Operating Cash Flow | -42,435 | -23,766 | -24,490 |
| Free Cash Flow | -42,435 | -23,766 | -24,490 |